Auteur/autrice : Eric Mawuli DJIRACKOR

Meet Simone Carter, McClatchy’s new Washington state government reporter  The Olympian
source

BlackRock says diversify your portfolio with gold and bitcoin  Investing.com
source

A student walks on the University of Utah campus in Salt Lake City in April. (Erika Bolstad/Stateline)
Utah is growing to be one of the most innovative states in the U.S. If you ask the Kem C. Gardner Policy Institute, their experts would say it ranks No. 1 among the other states for innovation capacity and outcomes. 
That ranking spot was determined because of the state’s Innovation Intelligence Index score, an Indiana Business Research Center metric that measures core attributes of innovations, including human capital, business dynamics, employment, productivity and economic well-being. However, the study also considered additional data from other “additional data from other credible sources and insights from in-depth interviews of Utah’s innovation ecosystem leaders and pioneers,” according to the report.
GET THE MORNING HEADLINES.
The Beehive State has a broad umbrella of industries that attract human capital and knowledge creation, according to a news release. Some of those are in “various levels of maturity,” the report found, making a deep emphasis on aeronautics; space exploration and defense; energy production; finance, fintech and headquarters; health care and life sciences; and technology and  information systems. 
Higher education institutions, highlighted as part of Utah’s innovation ecosystem in the report, offer degrees that align with those industries. And, the state allocates more funds to the schools compared to the national average. 
“For instance, Utah State University (USU) specializes in aerospace engineering and technology,” researchers wrote. “While the University of Utah excels in life sciences, health care, general engineering, and business degrees for financial services and fintech.”
Private institutions such as Brigham Young University, which is a leader in business programs, also contribute to this landscape, the report reads. 
The report comes after a legislative audit recommended cutting some low-performing programs and prioritizing degrees that attract students and improve their employment outcomes. Though the Utah System of Higher Education already collaborates with academic institutions and private companies to expand career opportunities, the study advises keeping collaborative partnerships between government, schools and industries.
In addition to changes in demands for certain degrees, students have also shifted other preferences in their learning experience — they would like more in-person collaboration and fewer lecture-based classes, a higher education leader told the researchers.
“This shift indicates a demand for a more experiential and interactive learning environment. Developing and expanding workforce training programs will help bridge the gap between academic and industry requirements,” the report reads. “Such programs should focus on equipping students with practical skills and an understanding of the cultural and environmental aspects of the future workplaces.”
The study, also co-led by the Economic Development Corporation of Utah (EDCUtah), explains that Utah’s success, apart from its higher education system, is attributed to “a well-trained workforce, social infrastructure, collaboration among innovation ecosystem actors, and a culture of innovation,” according to the release. 
“And with specific industry-aligned innovation ecosystems in Utah now identified, this initial evaluation highlights opportunities for their continued maturity and success,” Nate Lloyd, director of economic research at the Gardner Institute and lead author of the report, said in a statement.
YOU MAKE OUR WORK POSSIBLE.
by Alixel Cabrera, Utah News Dispatch
December 18, 2024
by Alixel Cabrera, Utah News Dispatch
December 18, 2024
Utah is growing to be one of the most innovative states in the U.S. If you ask the Kem C. Gardner Policy Institute, their experts would say it ranks No. 1 among the other states for innovation capacity and outcomes. 
That ranking spot was determined because of the state’s Innovation Intelligence Index score, an Indiana Business Research Center metric that measures core attributes of innovations, including human capital, business dynamics, employment, productivity and economic well-being. However, the study also considered additional data from other “additional data from other credible sources and insights from in-depth interviews of Utah’s innovation ecosystem leaders and pioneers,” according to the report.
GET THE MORNING HEADLINES.
The Beehive State has a broad umbrella of industries that attract human capital and knowledge creation, according to a news release. Some of those are in “various levels of maturity,” the report found, making a deep emphasis on aeronautics; space exploration and defense; energy production; finance, fintech and headquarters; health care and life sciences; and technology and  information systems. 
Higher education institutions, highlighted as part of Utah’s innovation ecosystem in the report, offer degrees that align with those industries. And, the state allocates more funds to the schools compared to the national average. 
“For instance, Utah State University (USU) specializes in aerospace engineering and technology,” researchers wrote. “While the University of Utah excels in life sciences, health care, general engineering, and business degrees for financial services and fintech.”
Private institutions such as Brigham Young University, which is a leader in business programs, also contribute to this landscape, the report reads. 
The report comes after a legislative audit recommended cutting some low-performing programs and prioritizing degrees that attract students and improve their employment outcomes. Though the Utah System of Higher Education already collaborates with academic institutions and private companies to expand career opportunities, the study advises keeping collaborative partnerships between government, schools and industries.
In addition to changes in demands for certain degrees, students have also shifted other preferences in their learning experience — they would like more in-person collaboration and fewer lecture-based classes, a higher education leader told the researchers.
“This shift indicates a demand for a more experiential and interactive learning environment. Developing and expanding workforce training programs will help bridge the gap between academic and industry requirements,” the report reads. “Such programs should focus on equipping students with practical skills and an understanding of the cultural and environmental aspects of the future workplaces.”
The study, also co-led by the Economic Development Corporation of Utah (EDCUtah), explains that Utah’s success, apart from its higher education system, is attributed to “a well-trained workforce, social infrastructure, collaboration among innovation ecosystem actors, and a culture of innovation,” according to the release. 
“And with specific industry-aligned innovation ecosystems in Utah now identified, this initial evaluation highlights opportunities for their continued maturity and success,” Nate Lloyd, director of economic research at the Gardner Institute and lead author of the report, said in a statement.
YOU MAKE OUR WORK POSSIBLE.
Utah News Dispatch is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity. Utah News Dispatch maintains editorial independence. Contact Editor McKenzie Romero for questions: info@utahnewsdispatch.com.
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our website. AP and Getty images may not be republished. Please see our republishing guidelines for use of any other photos and graphics.
Alixel Cabrera covers the status of diverse Utah communities, growth, infrastructure and education for Utah News Dispatch.
Utah News Dispatch is part of States Newsroom, the nation’s largest state-focused nonprofit news organization.
Democracy Toolkit
© Utah News Dispatch, 2024
v1.66.2
Utah News Dispatch is a nonprofit, nonpartisan news source covering government, policy and the issues most impacting the lives of Utahns.
We’re part of States Newsroom, the nation’s largest state-focused nonprofit news organization.
DEIJ Policy | Ethics Policy | Privacy Policy
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our website. (See full republishing guidelines.)
© Utah News Dispatch, 2024

source

Bitcoin Rally Pauses After Scaling $108,000 for the First Time  Yahoo Finance
source

LiveGood, a direct selling company launched just 13 months ago, has already reached the milestone of one million members. Focused on helping people through advanced nutritional supplementation made with results-driven ingredients, LiveGood operates as a membership-based program and differentiates itself through a lower-cost pricing strategy that prioritizes direct membership sales and affiliate marketing. Memberships provide access to wholesale product pricing and are available for $9.95 per month or $99.95 annually with the ability to cancel at any time. The company also offers an affiliate marketing opportunity that customers can leverage to earn money on products they share with others. 
The company’s growing product portfolio includes a variety of multivitamins and supplementations that target specific needs, like sleep aids, inflammation management, muscle recovery and weight management. All of them are manufactured in the US, have been produced in a cGMP/NSF certified manufacturing facility and were developed under the guide of LiveGood’s Director of Product Development Ryan Goodkin, who holds a doctorate in pharmacy and has a background as a natural health practitioner and pharmacist. 
“I don’t create products to sell,” Goodkin said. “I create products to use, and for my family to use. There is no way I am going to let my family put something in their body that I don’t trust 100%. That’s why I started LiveGood. I formulated every product. I know exactly what is in them. And I would not go a day without them!” 
LiveGood’s unique pricing strategy eliminates the “middle man” and instead delivers products directly to the consumer at a lower price point. This approach, which has already attracted one million members and counting, led the company to grow its revenue 3000% in its first full year, from $300,000 in 2022 to $92 million in 2023.
Members who are interested in developing a side hustle can utilize the company’s affiliate program to earn additional income by sharing the LiveGood memberships and products without the pressures of having to build or lead a team. 
“People need nutritional supplements to be healthy,” said Ben Glinsky, LiveGood Founder, who has more than two decades of experience leading successful nutritional supplement companies. “Unfortunately, most people just can’t afford them. On top of that, it’s very difficult for many people to sell expensive products to friends just so a few people at the top of a compensation program can make money. Now, people can get the products they need at prices they can afford, and can be proud to share them with friends.”
Breaking global news, emerging trends and powerful stories conveniently curated to help direct selling executives stay informed, engaged and a step ahead.

source

As bitcoin soars, luxury brands consider accepting crypto payments  Yahoo Finance
source

Payal Kapadia’s remarkable feature debut charts the daily lives of three women in Mumbai in a beautifully shot ode to the city and to the power of human connections
More on the best culture of 2024
“Evening is my favourite time of the day,” says a character in All We Imagine As Light, as twilight descends on Mumbai – it’s when the city comes alive. In the film-maker Payal Kapadia’s feature debut, which won the Grand Prix at Cannes, night-time in the city is shown in loving detail, as we see markets, fluorescently lit shops and trains full of women returning from work. Vermeer is famously said to have “painted with light”. The same principle seems to animate every frame of Kapadia’s film, as light delicately bounces around the screen, indicating the film’s interest in illuminating moments of hope as untold secrets lie in the shadows. On two occasions, a phone torch cuts through the dark to reveal words – in a notebook, on a cave wall – professing great love that feels otherwise impossible to say.
The film follows Prabha, Anu and Parvaty, who work as nurses and cooks at a hospital. The sensible Prabha (Kani Kusruti) is being courted by a doctor. She likes him, but she’s married. Though she is estranged from her husband, Prabha feels pressured to remain a loyal wife. Her roommate, the free-spirited Anu (Divya Prabha), is secretly seeing a Muslim man, and their love affair is as tender as it is aware of the politics undermining their match. Would her father approve, he asks, “if I used a Hindi name”? The two women are also helping Parvaty (Chhaya Kadam), who is being evicted from her home by developers. A banner across her building shows a city on the march to gentrification: “Class,” it announces, “is a privilege reserved for the privileged!”
All three stories are concerned with the ways in which politics shapes individual lives, which is a longstanding interest of Kapadia’s – her first film, A Night of Knowing Nothing, is a documentary exploring the 2015 student protests against Narendra Modi’s appointment of political sympathiser as a university chair (Kapadia was also a leading figure in the protests). In All We Imagine As Light, each woman’s personal circumstances are depicted with humanity and subtlety, and the film also gives a sense that they’re not alone. One night, Prabha talks to Anu about her failed marriage. As she talks wistfully of the past, the camera surveys the tower blocks of Mumbai, with some apartments still dotted with light. Listening to Prabha’s monologue against this wide open vista, one begins to wonder: how many other women are out there with the same thwarted desires, the same pain? At a time when political forces all across the world are performing acts of closure – narrowing our understanding of who we can call neighbours, fellow citizens, lovers – All We Imagine As Light looks out into the world with roving empathy and curiosity, finding in it moments of intimacy and connection, and plenty to love.

source

Advertisement
International Journal of Emergency Medicine volume 17, Article number: 189 (2024) Cite this article
Metrics details
Chenopodium album, commonly known as “lambsquarters,” is a plant consumed as food and used in traditional medicine. Its popularity is increasing due to the belief that it has fewer side effects compared to synthetic drugs. However, its use can lead to acute or chronic poisoning. The growing interest in herbal remedies, along with uncontrolled usage and disregard for expert recommendations, contributes to adverse effects.
: A 68-year-old female patient presented to the emergency department with nausea, vomiting, and flank pain following the use of lambsquarters. Impaired kidney function was detected in the patient. A biopsy performed after Chenopodium album usage led to the diagnosis of tubulointerstitial nephritis (TIN). The patient responded positively to corticosteroid and hemodialysis treatment.
Caution is necessary in the use of herbal medicines and traditional treatments. A thorough evaluation of factors such as patients’ nutritional status, herbal product usage, medication history, and genetic background is crucial. Chenopodium album can cause tubulointerstitial nephritis, resulting in kidney damage. Similarly, heavy metal poisoning through herbal products can lead to kidney damage. Adopting a multidisciplinary approach in the diagnosis and treatment process can contribute to better patient management.
This case presents a rare instance of tubulointerstitial nephritis developed due to the use of herbal products. Physicians should inquire about patients’ history of exogenous substance use and conduct a comprehensive assessment, keeping such situations in mind. Conscious use of herbal medicines and traditional treatments can help prevent serious complications like kidney damage.
Chenopodium album, also known colloquially as “lambsquarters” (Fig. 1), is a plant widely consumed as food in many cultures and utilized in certain traditional medical practices. This herbal food has been gaining popularity, attributed to the belief that herbal medicines have fewer side effects compared to synthetic drugs [1]. However, its use can significantly contribute to incidents of acute or chronic poisoning. Poison control centers admit over 100,000 patients exposed to toxic plants, with the majority involving minor toxicities related to the ingestion of medicinal plants in small quantities. In most severe poisoning cases, individuals consume a toxic plant either accidentally or with the intention of utilizing its therapeutic properties [2]. In recent years, the increasing interest in herbal remedies, uncontrolled usage of herbal products, and the disregard for recommendations from healthcare professionals prior to use have exacerbated the negative effects associated with these products [3]. An estimated one-third of adults in developed countries and over 80% of the population in many low- and middle-income countries use herbal and traditional medicines to enhance health or treat common illnesses. Herbal medicines can lead to kidney damage due to toxicity, contamination, misidentification, mislabeling, and adverse plant-drug interactions. The kidneys are particularly sensitive to toxic damage due to their high blood flow, extensive endothelial surface area, high metabolic activity, active uptake by tubular cells, medullary interstitial concentration, and low urine pH. Kidney damage can manifest as nephrolithiasis, chronic interstitial fibrosis, uroepithelial cancer, crystalluria, or hypertension, with some plants increasing potassium levels in those with kidney damage. The regulation of herbal and traditional medicines by global health organizations is critical to reduce the risk of acute kidney injury or chronic kidney disease associated with plant consumption. Nephrologists should be aware of potential nephrotoxicity arising from herbal medicines and supplements [4]. Additionally, some studies indicate that patients using alternative medicines may experience complications such as acute kidney injury (AKI) due to heavy metal poisoning. Defining the use of traditional herbal medicines as a source of toxicity can be challenging [5]. Tubulointerstitial nephritis (TIN) is a condition that can lead to chronic kidney disease (CKD), a common cause of kidney damage. TIN progresses to fibrosis in the renal interstitium through immune-mediated inflammation by inflammatory cells. Patients may present with nonspecific symptoms, and delays in the diagnosis and treatment of the disease can occur if not suspected. Etiologically, drugs, infectious agents, toxins, idiopathic causes, genetic factors, inflammatory bowel disease, or systemic inflammatory conditions associated with immunoglobulin G4 (IgG4) may lead to TIN. Clinical suspicion for TIN is necessary for diagnosis and treatment. Treatment depends on the underlying etiology, with corticosteroids forming the cornerstone of therapy [6]. In this case, a patient who used Chenopodium album for weight loss and experienced impaired kidney function was diagnosed with ATIN following a kidney biopsy. The patient benefited from corticosteroid and hemodialysis treatment. A literature review revealed that this is the first reported case of ATIN following the use of Chenopodium album.
Coltsfoot (Chenopodium album) is widely used in alternative medicine
A 68-year-old female patient presented to the emergency department with complaints of nausea, vomiting, and flank pain. She reported a history of using lambsquarters for weight loss for seven consecutive days two weeks prior. The patient had no chronic diseases except for diabetes mellitus and was taking metformin 500 mg/day. Upon admission, her vital signs were stable (temperature: 36.2 °C, blood pressure: 129/71 mm Hg, respiratory rate: 18/min, pulse rate: 88/min), and physical examination revealed findings such as arthralgia, edema, and rash. Laboratory investigations showed elevated serum blood urea nitrogen (BUN) at 40.4 mg/dL, creatinine at 2.84 mg/dL, and potassium at 6.1 meq/L. The complete urine analysis indicated leukocytes, leukocyte casts, and erythrocytes (Table 1), (Fig. 2). Two months ago, the serum creatinine was 0.82 mg/dL, and a renal ultrasound showed no abnormalities except for a grade 2 increase in bilateral parenchymal echoes. The patient was admitted to the nephrology clinic for further investigation of the etiology of acute kidney failure and initiation of treatment. On the first day of follow-up, despite medical treatment, hemodialysis was initiated due to persistently high potassium levels (Fig. 3). Following hemodialysis, a kidney biopsy was planned, performed, and pathology consultation was sought. The light microscopy of the kidney biopsy, evaluated with four glomeruli, revealed sclerosis in two glomeruli, thickening of the Bowman capsule in one glomerulus, tubular atrophy, interstitial fibrosis, and mononuclear inflammatory cell infiltration with dense eosinophils in the interstitium. Immunofluorescence showed no deposits (Fig. 3). Given the clinical indications of tubulointerstitial nephritis (TIN), corticosteroid therapy at a dose of 80 mg/day was initiated (Fig. 4). The patient’s metformin, used for diabetes, was discontinued, and insulin therapy was initiated. The patient underwent hemodialysis on the 2nd and 4th days of follow-up, continuing the same dose of steroid therapy. On the fifth day, evaluation revealed a decrease in creatinine levels to 2.33 mg/dL and a reduction in nausea and vomiting symptoms (Fig. 4), (Table 1). The temporary hemodialysis catheter was removed after hemodialysis, and steroid therapy continued at a dose of 64 mg/day. On the 11th day of follow-up, with no remaining complaints, the steroid dose was reduced by 16 mg to 48 mg/day. Linagliptin was initiated for diabetes regulation, and the patient was discharged for outpatient follow-up. Upon returning for a checkup five days later, her creatinine levels had returned to baseline at 0.89 mg/dL (Table 1). Steroid dosage was gradually reduced during follow-ups and discontinued over four weeks.
Leukocytes, leukocyte casts, and clusters of erythrocytes in urine sediment under the light microscope
Renal function and treatment course. HD: Hemodialysis
Black arrows indicate crystals in renal tubules, while blue arrows demonstrate hemosiderin accumulation in renal tubule epithelium under light microscopy. (H&E, × 200)
We presented in detail a case of AIN that emerged in a patient who consumed Chenopodium album for one week. To the best of our knowledge, this report represents the first such case in the literature. There are many cases of kidney failure in the clinical setting with unexplained etiology. This case emphasizes the importance of careful use of medications, including herbal medicines and traditional treatments. It highlights the necessity for healthcare professionals to obtain a comprehensive history, including factors such as nutritional status, herbal product usage, medication history, and genetic background, to understand the patient’s condition better. Moreover, it underscores the need for further research on the side effects of herbal products.
Chenopodium album is known to be consumed in various regions of the world, believed to have protective effects against hepatotoxicity induced by carbon tetrachloride according to animal experiments [7,8,9]. However, there is insufficient research on its side effects, interactions with drugs, and the potential for contamination with heavy metals.
AIN is usually confirmed when histological findings such as interstitial inflammation, edema, and tubulitis accompany acute kidney injury (AKI). The etiology of AIN is diverse, with known causes including drugs, various infections, autoimmune or systemic diseases, and idiopathic conditions. Several studies have shown that drugs are the most common etiology of AIN. Furthermore, AIN reported after the intake of herbal medicines has been documented [10]. In our case, the presence of findings such as tubular atrophy, interstitial fibrosis, and mononuclear inflammatory cell infiltration with dense eosinophils in the interstitium led to the diagnosis of AIN (Fig. 3).
The pathogenesis of AIN typically involves allergic reactions triggered by exposure to a specific drug. T-cell-mediated hypersensitivity reactions and cytotoxic T-cell injuries play a role in the pathogenesis of AIN [11]. The exact disease mechanism leading to AIN caused by Chenopodium album is not clear based on the current data. Additionally, the kidneys are a sensitive organ to heavy metal poisoning, which can occur due to both acute and chronic exposure. Heavy metals taken into the body can lead to kidney lesions such as acute tubular necrosis, cortical necrosis, and interstitial nephritis. Exposure to heavy metals, both acutely and chronically, can cause tubulointerstitial injuries without any marked morphological changes, and these can manifest within days after exposure to the toxic substance. Heavy metal exposure constitutes a significant yet inadequately understood cause of kidney damage. The pathology findings, including crystals seen in the tubules, suggest this possibility. However, the absence of symptoms commonly observed in heavy metal poisoning cases, such as encephalopathy, seizures, mental status changes, papilledema, ataxia, and abdominal pain, makes this diagnosis challenging [12, 13].
The cornerstone of AIN treatment is discontinuation of the suspected nephrotoxic agent. There is a general consensus that when there is no evidence of improvement in kidney function after 5–7 days following the discontinuation of the suspected toxin, treatment, especially with steroids initiated promptly, may be beneficial. The rationale for this approach is that early corticosteroids may reduce the inflammatory infiltration of the renal interstitium and thereby prevent later fibrosis risk [11, 14]. In our case, a thorough evaluation of history, physical examination, laboratory, and pathological findings led to the initiation of steroid therapy, combined with hemodialysis due to electrolyte disturbances, acidosis, and uremic symptoms, resulting in a positive outcome.
In conclusion, we aimed to provide a multidisciplinary perspective on the diagnosis and management of AIN following the use of herbal products through this case. Physicians should inquire about the history of exogenous substance use and conduct a comprehensive assessment, keeping such situations in mind. Conscious use of herbal medicines and traditional treatments can help prevent serious complications like kidney damage.
No datasets were generated or analysed during the current study.
Çalka Ö, Akdeniz N, Metin A, Behçet L. Phototoxic dermatitis due to Chenopodium album in a mother and son. Contact Dermat. Jul. 2005;53(1):58–60. https://doi.org/10.1111/J.0105-1873.2005.0456E.X.
Froberg B, Ibrahim D, Furbee RB. Plant poisoning., Emerg Med Clin North Am, 25, 2, pp. 375–433; abstract ix, May 2007, https://doi.org/10.1016/j.emc.2007.02.013
Jurčić D, et al. Herbalife^® associated severe hepatotoxicity in a previously healthy woman. Acta Clin Croat. Dec. 2019;58(4):771–6. https://doi.org/10.20471/ACC.2019.58.04.26.
Del Granado RC, Espinosa-Cuevas M. Herbal Nephropathy, Contrib Nephrol, vol. 199, pp. 143–154, Nov. 2021, https://doi.org/10.1159/000517693
Moorthy S, Samuel AE, Moideen F, Peringat J. Interstitial nephritis presenting as acute kidney Injury following ingestion of Alternative Medicine containing lead: a Case Report. Adv J Emerg Med. 2018;3(1):e8. https://doi.org/10.22114/AJEM.V0I0.100.
Article  PubMed  PubMed Central  Google Scholar 
Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring, Pediatr Nephrol, vol. 32, no. 4, pp. 577–587, Apr. 2017, https://doi.org/10.1007/S00467-016-3394-5
Khoobchandani M, Ojeswi BK, Sharma B, Srivastava MM. Chenopodium album prevents progression of cell growth and enhances cell toxicity in human breast cancer cell lines. Oxid Med Cell Longev. 2009;2(3):160–5. https://doi.org/10.4161/OXIM.2.3.8837.
Article  PubMed  PubMed Central  Google Scholar 
Chamkhi I, et al. Genetic diversity, antimicrobial, nutritional, and phytochemical properties of Chenopodium album: a comprehensive review. Food Res Int. Apr. 2022;154. https://doi.org/10.1016/J.FOODRES.2022.110979.
Hussain S, Asrar M, Rasul A, Sultana S, Saleem U. Chenopodium album extract ameliorates carbon tetrachloride induced hepatotoxicity in rat model. Saudi J Biol Sci. May 2022;29(5):3408–13. https://doi.org/10.1016/J.SJBS.2022.02.014.
Krishnan N, Moledina DG, Perazella MA. Toxic nephropathies of the Tubulointerstitium: Core Curriculum 2024. Am J Kidney Dis. 2024. https://doi.org/10.1053/J.AJKD.2023.09.017.
Article  PubMed  Google Scholar 
Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A, Aoun B. Acute tubulointerstitial nephritis, Pediatr Nephrol, vol. 27, no. 7, pp. 1051–1057, Jul. 2012, https://doi.org/10.1007/S00467-011-1915-9
Kosiba AA, Wang Y, Chen D, Wong CKC, Gu J, Shi H. Feb., The roles of calcium-sensing receptor (CaSR) in heavy metals-induced nephrotoxicity, Life Sci, 242, 2020, https://doi.org/10.1016/J.LFS.2019.117183
Fowler BA. Mechanisms of kidney cell injury from metals. Environ Health Perspect. 1993;100:57–63. https://doi.org/10.1289/EHP.9310057.
Article  CAS  PubMed  PubMed Central  Google Scholar 
Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring, Pediatric Nephrology, vol. 32, no. 4, pp. 577–587, Apr. 2017, https://doi.org/10.1007/s00467-016-3394-5
Download references
Not applicable.
This study received no financial support.
Department of Internal Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey
Alparslan Demiray
Department of Pathology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
Sevil Demiray & Hülya Akgün
Department of Nephrology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
Tuğba Yılmaz & İsmail Koçyiğit
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
Author Contributions: Alparslan Demiray (A.D.): Designed the manuscript, followed the patient, and wrote the article. Tugba Yılmaz (T.Y.): Conducted the literature review and contributed to the writing of the article. Ismail Koçyiğit (İ.K.): Contributed to the conceptualization of the article, patient follow-up, and provided assistance in ensuring the academic strength of the manuscript. Pathological evaluation was performed by Sevil Demiray (S.D.) and Hülya Akgün (H.A.). H.A. conducted the examination of the kidney biopsy, and S.D. made significant contributions to this examination process, contributing significantly to the academic richness of the article.
Correspondence to Alparslan Demiray.
Ethical approval and participant consent not applicable for this case report.
Written informed consent was obtained from the patient for the publication of this case report.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Reprints and permissions
Demiray, A., Yılmaz, T., Demiray, S. et al. A case of acute tubulointerstitial nephritis following the use of chenopodium album L. Int J Emerg Med 17, 189 (2024). https://doi.org/10.1186/s12245-024-00790-3
Download citation
Received: 20 March 2024
Accepted: 07 December 2024
Published: 18 December 2024
DOI: https://doi.org/10.1186/s12245-024-00790-3
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative
Advertisement
ISSN: 1865-1380
By using this website, you agree to our Terms and Conditions, Your US state privacy rights, Privacy statement and Cookies policy. Your privacy choices/Manage cookies we use in the preference centre.
© 2024 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.

source

How to keep your pets safe from snow salts  WSBT-TV
source

December 18, 2024 07:15 ET  | Source: BCC Research LLC BCC Research LLC
Boston, Dec. 18, 2024 (GLOBE NEWSWIRE) — According to the latest study from BCC Research the “Global Market for Medical Device Technologies” is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
This report is relevant due to the rapid advances in technology and the integration of AI in medical devices. As healthcare systems worldwide continue to evolve post-pandemic, the demand for innovative, technology-oriented devices has surged, prompting the need for examine market trends and developments. This report covers not only the current landscape but also anticipates future shifts in this dynamic market.
The report analyzes the medical device technology market, focusing on trends and market estimate through 2029. It evaluates the positioning of the major players and their product portfolios while assessing regulatory scenarios and emerging technologies. The market is segmented by device type, including drug delivery devices, in vitro diagnostics (IVD), urology and renal devices, orthopedics and spine, imaging devices, cardiovascular devices, and endoscopy. Imaging devices encompass X-rays, ultrasound and computed tomography. IVDs are categorized into immunochemistry, clinical chemistry and molecular diagnostics. The report also segments the market by end-users, such as hospitals, home healthcare, and diagnostic centers, while providing analysis of the markets North America, Europe, Asia-Pacific, and the Rest of the World, with specific focus on the U.S., Germany, the U.K. and Japan.
Click here for more details on the “Global Market for Medical Devices” report.
The following factors are driving the global market for medical devices:
Aging Population: More elderly people means a higher demand for devices to diagnose and manage age-related health issues.
AI Integration: AI enhances diagnostic accuracy and speeds up data analysis.
Chronic Diseases: Increasing cases of diabetes, cancer, and heart disease drive the need for advanced monitoring and treatment devices.
Public Health Improvement: Better healthcare infrastructure and access boost the demand for essential medical tools.
Enhanced Diagnosis: Technological advances make diagnostic devices more precise, faster, and less invasive.
Patient Education: Informed patients seek out the best medical technologies for managing their health.
Request a sample copy of Medical Devices: Technologies and Global Markets
Report Synopsis
Interesting facts:
The report addresses the following questions:
Leading companies in the market include:
Related Reports
Infusion Pumps and Devices: Technologies and Global Markets: This report provides insights into the infusion pump market, including market projections through 2029 and the market shares of key players. It analyzes the market by products, applications, and end users. Infusion pumps are categorized into general-purpose types, such as large-volume, syringe, electronic ambulatory, and elastomeric pumps, as well as specialty types, including insulin, patient-controlled analgesia, enteral, and implantable pumps.
3D Printing Medical Devices: Global Markets: This report analyzes trends in the global market for 3D printing medical devices. The report highlights emerging technologies and the competitive landscape, providing profiles of the major companies.
Purchase a copy of the report directly from BCC Research.
For further information or to purchase a report, please contact info@bccresearch.com.
About BCC Research
BCC Research reports provide objective, unbiased measurement and assessment of market opportunities. Our industry analysts’ goal is to help readers make informed business decisions, free of noise and hype.

source